This inventor holds 1 USPTO granted patent and 4 EPO patents. Top assignee: R-Tech Ueno, Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Makoto Takewaki: Innovator in Pharmaceutical Development
Introduction
Makoto Takewaki is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His work exemplifies the intersection of innovation and healthcare.
Latest Patents
Makoto Takewaki holds a patent for a thiazole derivative, which serves as a VAP-1 inhibitor. This invention provides a pharmaceutical agent for the prophylaxis or treatment of VAP-1 associated diseases. The thiazole derivative is represented by the formula (I): R—NH—X—Y—Z, where each symbol is defined in the specification. This compound, or its pharmaceutically acceptable salt, has potential applications in medical treatments.
Career Highlights
Throughout his career, Takewaki has been associated with R-Tech Ueno, Ltd., where he has contributed to various innovative projects. His expertise in pharmaceutical development has positioned him as a key figure in the industry.
Collaborations
Some of his notable coworkers include Tatsuya Matsukawa and Kazuhiro Masuzaki. Their collaborative efforts have further advanced the research and development initiatives at R-Tech Ueno, Ltd.
Conclusion
Makoto Takewaki's work in developing thiazole derivatives highlights his commitment to advancing pharmaceutical science. His contributions are vital in the ongoing fight against diseases associated with VAP-1.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile